1. Home
  2. NKTR vs BCML Comparison

NKTR vs BCML Comparison

Compare NKTR & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • BCML
  • Stock Information
  • Founded
  • NKTR 1990
  • BCML 2004
  • Country
  • NKTR United States
  • BCML United States
  • Employees
  • NKTR N/A
  • BCML N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • NKTR Health Care
  • BCML Finance
  • Exchange
  • NKTR Nasdaq
  • BCML Nasdaq
  • Market Cap
  • NKTR 238.7M
  • BCML 261.8M
  • IPO Year
  • NKTR 1994
  • BCML N/A
  • Fundamental
  • Price
  • NKTR $1.30
  • BCML $23.48
  • Analyst Decision
  • NKTR Buy
  • BCML
  • Analyst Count
  • NKTR 4
  • BCML 0
  • Target Price
  • NKTR $2.50
  • BCML N/A
  • AVG Volume (30 Days)
  • NKTR 1.0M
  • BCML 19.5K
  • Earning Date
  • NKTR 11-05-2024
  • BCML 10-21-2024
  • Dividend Yield
  • NKTR N/A
  • BCML 1.67%
  • EPS Growth
  • NKTR N/A
  • BCML N/A
  • EPS
  • NKTR N/A
  • BCML 2.12
  • Revenue
  • NKTR $93,157,000.00
  • BCML $97,490,000.00
  • Revenue This Year
  • NKTR N/A
  • BCML N/A
  • Revenue Next Year
  • NKTR N/A
  • BCML $3.40
  • P/E Ratio
  • NKTR N/A
  • BCML $11.02
  • Revenue Growth
  • NKTR 6.17
  • BCML N/A
  • 52 Week Low
  • NKTR $0.41
  • BCML $18.54
  • 52 Week High
  • NKTR $1.93
  • BCML $25.04
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 53.91
  • BCML 54.46
  • Support Level
  • NKTR $1.26
  • BCML $23.27
  • Resistance Level
  • NKTR $1.42
  • BCML $23.62
  • Average True Range (ATR)
  • NKTR 0.09
  • BCML 0.37
  • MACD
  • NKTR 0.01
  • BCML -0.06
  • Stochastic Oscillator
  • NKTR 61.29
  • BCML 24.07

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: